McDermott and Bull executive Search
 

Other News

PhaseBio Reports First-Quarter 2021 Financial Results and Recent Business Highlights

Continued enrollment progress in Phase 3 REVERSE-IT clinical trial for Bentracimab Signed commercial supply agreement with BioVectra to support development and commercialization of lead product candidate bentracimab Completed underwritten public offering of common stock yielding $60.1 million in net proceeds May 13, 2021 04:00 PM Eastern Daylight Time MALVERN, Pa. […]

PaceMate™ Announces Medical Advisory Board

BRADENTON, Fla.–(BUSINESS WIRE)–PaceMate™, the leading digital technology company in healthcare data management, is pleased to announce the appointment of seven cardiac electrophysiologist professionals as members of the company’s medical advisory board. As PaceMate™ continues forward in its mission to advance efficient digital healthcare solutions through innovative technology and its compassion-driven […]

Philips introduces integrated Interventional Hemodynamic System with Patient Monitor IntelliVue X3 to improve workflow and patient focus during image-guided procedures at ACC.21

May 14, 2021 Continuous monitoring provides informed, timely clinical decision making and comprehensive, gap-free patient records in the cath lab and beyond Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the integration of its Interventional Hemodynamic System and market-leading portable Patient Monitor IntelliVue X3, providing […]

Cardax Reports Q1 2021 Results

– Operating loss decreased vs. Q1 2020 – Net loss increased vs. Q1 2020 – ZanthoSyn® revenues decreased vs. Q1 2020 – Company pursuing multiple funding opportunities HONOLULU, May 14, 2021 /PRNewswire/ — Cardax, Inc. (OTCQB:CDXI) reported its Q1 2021 results. Highlights: Financial Results. Operating loss decreased from $906,031 in Q1 2020 to $771,312 in Q1 2021 […]

Windtree Therapeutics Reports First Quarter 2021 Financial Results and Provides Key Business Updates

WARRINGTON, Pa., May 13, 2021 /PRNewswire/ — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today reported financial results for the first quarter ended March 31, 2021 and provided key business updates. Key Business and Financial Updates Expanded the participating […]

Tampa General Hospital/USF Health Interventional Cardiology Team Adopts New Intravascular Imaging Technology and Performs First Case in the World

TAMPA, Fla., May 12, 2021 /PRNewswire/ — Tampa General Hospital and USF Health’s Interventional Cardiology team has adopted new intravascular technology and successfully treated the first patient in the world. Tampa General has built a legacy as an early adopter of intravascular imaging for coronary intervention and continues to seek the newest and […]

St. Elizabeth Healthcare Enhances Access To Cardiac Care With Multi-specialty Outpatient Building

Heart & Vascular Institute Expansion and Community Partnerships Lead to Decrease in Heart-Related Deaths EDGEWOOD, Ky., May 13, 2021 /PRNewswire/ — St. Elizabeth Healthcare is increasing access to quality cardiac care in the Northern Kentucky community with system-wide enhancements to the Heart & Vascular Institute (HVI), including the construction of a new, 67,000-square-foot facility in Edgewood and expansions to the […]

Acutus Medical Announces CE Mark Approval for Suite of Next Generation EP Products in Europe

Expanded and Product Portfolio Strengthens Offering in Access and Therapy Guidance CARLSBAD, Calif., May 12, 2021 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced CE Mark Approval for a broad suite of […]

Liquidia Reports First Quarter 2021 Financial Results and Provides Corporate Update

– Doubled the market opportunity for Treprostinil Injection by adding subcutaneous delivery – Resubmitted New Drug Application for LIQ861 (treprostinil) Inhalation Powder – Improved financial position with private placement and access to new credit facility – Company to host webcast and conference call today at 8:30 a.m. ET MORRISVILLE, N.C., May […]